Discriminative Stimulus Properties of Opioid Ligands: Progress and Future Directions.
Discriminative Stimulus Properties of Opioid Ligands: Progress and Future Directions.
复制标题
DOI：
10.1007/7854_2016_9
复制
发表时间：
2016-05
影响因子：
--
通讯作者：
E. Butelman;M. Kreek
中科院分区：
文献类型：
--
作者：
E. Butelman;M. Kreek
Opioid receptors (MOP-r, KOP-r, DOP-r, as well as NOP-r) and their endogenous neuropeptide agonist systems are involved in diverse neurobiological and behavioral functions, in health and disease. These functions include pain and analgesia, addictions, and psychiatric diseases (e.g., depression-, anxiety-like, and stress-related disorders). Drug discrimination assays have been used to characterize the behavioral pharmacology of ligands with affinity at MOP-r, KOP-r, or DOP-r (and to a lesser extent NOP-r). Therefore, drug discrimination studies with opioid ligands have an important continuing role in translational investigations of diseases that are affected by these neurobiological targets and their pharmacotherapy.
